3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 37.55
-1.60 (-4.09%)
Mar 9, 2026, 1:59 PM CST
3D Global Biotech Revenue
3D Global Biotech had revenue of 102.84M TWD in the half year ending June 30, 2025, with 1,024.22% growth. This brings the company's revenue in the last twelve months to 324.87M, up 489.06% year-over-year. In the year 2024, 3D Global Biotech had annual revenue of 265.69M with 1,187.68% growth.
Revenue (ttm)
324.87M
Revenue Growth
+489.06%
P/S Ratio
9.00
Revenue / Employee
7.56M
Employees
43
Market Cap
2.92B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.14B |
| Apex Biotechnology | 1.96B |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Intech Biopharm | 113.85M |
| GlycoNex Incorporation | 36.63M |
| BRIM Biotechnology | 3.17M |
| Sagittarius Life Science | 424.44M |
| Sunny Pharmtech | 290.18M |